1. Ethnicity and association with ocular, systemic manifestations and prognosis in 194 patients with sarcoid uveitis
- Author
-
Sabine Jardel, Carole Burillon, Charlotte Coulon, Pascal Sève, Laurent Perard, Laurent Kodjikian, Christiane Broussolle, Yvan Jamilloux, and Cédric Rochepeau
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Sarcoidosis ,Biopsy ,Ethnic group ,Disease ,Uveitis ,03 medical and health sciences ,Cellular and Molecular Neuroscience ,0302 clinical medicine ,0502 economics and business ,Ethnicity ,medicine ,Humans ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,Incidence ,05 social sciences ,Panuveitis ,Middle Aged ,Prognosis ,medicine.disease ,Dermatology ,Sensory Systems ,Ophthalmology ,Bronchoalveolar lavage ,030221 ophthalmology & optometry ,Intermediate uveitis ,Female ,050211 marketing ,France ,business ,Tomography, Optical Coherence ,Sarcoid uveitis ,Follow-Up Studies - Abstract
To determine the ophthalmological and extra-ophthalmological clinical characteristics and visual prognosis of patients with sarcoid uveitis in different ethnic groups. We retrospectively analysed the data from patients with sarcoid uveitis seen at two departments of Ophthalmology between December 2003 and December 2017. Patients presented biopsy-proven sarcoidosis and/or presumed sarcoid uveitis based on the following criteria: compatible thoracic imaging, associated with elevated angiotensin-conversion enzyme (ACE) and/or lymphocytic alveolitis on bronchoalveolar lavage fluid analysis (> 15% lymphocytes and CD4/CD8 > 3.5). Ophthalmological and general characteristics, as well as visual and global prognoses, were compared in three pre-defined ethnic groups: White Europeans, North Africans and Afro-Caribbeans. A total of 194 patients were included: 145 with biopsy-proven and 49 with presumed sarcoid uveitis. Overall, 68% were White Europeans while 20.6% were North Africans and 11.3% were Afro-Caribbeans. Sixty-nine per cent were women and the median age at presentation was 52.1 years. Median ages at first ocular manifestation of the disease in Afro-Caribbeans and North Africans were respectively 34.3 and 43.1 years, while it was 57.8 years in White Europeans (p
- Published
- 2019